Related Experiment Videos
[Blood glucose and intracranial surgery]
P De Stefanis1, E Auci, R Romano
1Istituto Polidisciplinare, Università deli Studi di Trieste, Anestesia, Rianimazione e Terapia Antalgica.
Minerva Anestesiologica
|September 1, 1994
Summary
Glucose administration may be contraindicated during cerebral ischemia. This study found that avoiding dextrose during intracranial surgery in non-diabetic patients did not cause hypoglycemic episodes, suggesting it can be safely omitted.
Area of Science:
- Neuroscience
- Anesthesiology
- Metabolism
Background:
- Cerebral ischemia, a condition of reduced blood flow to the brain, raises concerns about glucose metabolism.
- The role of glucose administration during neurosurgery, particularly in the context of potential cerebral ischemia, requires clarification.
Purpose of the Study:
- To investigate the safety and necessity of dextrose administration during elective intracranial surgery in non-diabetic patients.
- To determine if avoiding glucose infusion prevents hypoglycemic episodes in this surgical context.
Main Methods:
- Seventeen non-diabetic patients undergoing elective intracranial surgery were studied.
- Intraoperative management excluded dextrose administration.
- Perioperative glycemic levels and hypoglycemic episodes were monitored.
Main Results:
- No hypoglycemic episodes were observed in any of the 17 patients during the surgical procedures.
- Mean surgical duration was 218.8 +/- 42.8 minutes, indicating prolonged procedures were tolerated without dextrose.
- Patients remained normoglycemic throughout the surgery without exogenous glucose support.
Conclusions:
- Dextrose administration can be safely avoided during elective intracranial surgery in non-diabetic patients.
- Omitting dextrose does not appear to lead to adverse sequelae, including hypoglycemia.
- These findings challenge the routine use of dextrose in this specific patient population and surgical setting.